2012
DOI: 10.1126/scitranslmed.3003377 View full text |Buy / Rent full text
|
|

Abstract: Adverse drug events remain a leading cause of morbidity and mortality around the world. Many adverse events are not detected during clinical trials before a drug receives approval for use in the clinic. Fortunately, as part of postmarketing surveillance, regulatory agencies and other institutions maintain large collections of adverse event reports, and these databases present an opportunity to study drug effects from patient population data. However, confounding factors such as concomitant medications, patient… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
3
506
0
2

Publication Types

Select...

Relationship

0
0

Authors

Journals